
Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
Author(s) -
Yuanyuan Dai,
Wenjiao Chang,
Xiuyan Zhou,
Wei Yu,
Can Huang,
Yunbo Chen,
Xiaoling Ma,
Huaiwei Lu,
Rujin Ji,
Ying Chen,
Peipei Wang,
Zhiying Liu,
Qing-feng Yuan,
Yonghong Xiao
Publication year - 2021
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s309825
Subject(s) - regimen , pseudomonas aeruginosa , ceftazidime/avibactam , ceftazidime , enterobacteriaceae , medicine , minimum inhibitory concentration , avibactam , microbiology and biotechnology , chemistry , antibiotics , biology , escherichia coli , bacteria , biochemistry , genetics , gene
To evaluate the administration regimen of ceftazidime/avibactam (CZA) for bloodstream infections caused by Enterobacteriaceae and Pseudomonas aeruginosa .